CLOPIDOGREL BISULFATE
NDC 64980-713, CLOPIDOGREL BISULFATE, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-713
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204359
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-713 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLOPIDOGREL BISULFATE75 mg/1
Pharmacologic classes
Cytochrome P450 2C8 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-713-03 | 64980071303 | 30 TABLET in 1 BOTTLE (64980-713-03) |
| 64980-713-09 | 64980071309 | 90 TABLET in 1 BOTTLE (64980-713-09) |
| 64980-713-50 | 64980071350 | 500 TABLET in 1 BOTTLE (64980-713-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/ab32a331-2cea-453b-bba1-5451d38edd73
Use it
Look up 64980-713 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-713 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-713. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.